Precise Readout of MEK1 Proteoforms upon MAPK Pathway Modulation by Individual Ion Mass Spectrometry.
Bryon S DrownRaveena GuptaJohn P McGeeMichael A R HollasPaul J HergenrotherJared O KafaderMichael P SnyderPublished in: Analytical chemistry (2024)
The functions of proteins bearing multiple post-translational modifications (PTMs) are modulated by their modification patterns, yet precise characterization of them is difficult. MEK1 (also known as MAP2K1) is one such example that acts as a gatekeeper of the mitogen-activating protein kinase (MAPK) pathway and propagates signals via phosphorylation by upstream kinases. In principle, top-down mass spectrometry can precisely characterize whole MEK1 proteoforms, but fragmentation methods that would enable the site-specific characterization of labile modifications on 43 kDa protein ions result in overly dense tandem mass spectra. By using the charge-detection method called individual ion mass spectrometry, we demonstrate how complex mixtures of phosphoproteoforms and their fragment ions can be reproducibly handled to provide a "bird's eye" view of signaling activity through mapping proteoform landscapes in a pathway. Using this approach, the overall stoichiometry and distribution of 0-4 phosphorylations on MEK1 was determined in a cellular model of drug-resistant metastatic melanoma. This approach can be generalized to other multiply modified proteoforms, for which PTM combinations are key to their function and drug action.
Keyphrases
- mass spectrometry
- pi k akt
- drug resistant
- protein kinase
- signaling pathway
- liquid chromatography
- high resolution
- multidrug resistant
- gas chromatography
- capillary electrophoresis
- high performance liquid chromatography
- acinetobacter baumannii
- oxidative stress
- quantum dots
- cell proliferation
- emergency department
- cystic fibrosis
- heat shock protein
- density functional theory
- pseudomonas aeruginosa
- nuclear factor
- molecular dynamics
- protein protein
- adverse drug